Continue on TOI App
Open App
OPEN APP

Our drug priced lower, Glenmark says in defence

MUMBAI: Mumbai-based

Glenmark

defended the pricing to the drug regulator of its

Covid-19

drug, FabiFlu (Favipiravir) on Tuesday, saying it’s lower as compared to other countries, and as against therapies approved under ‘

emergency use

’.

Tired of too many ads?go ad free now


In a response to DCGI seeking clarification on the pricing and claims on Covid-19 drug, the company said both — clinical trials and restricted use approval, were preceded by multiple dialogues, deliberations and consideration before the Subject Expert Committee, constituted by Ministry of Health & Family Welfare.

The price of Favipiravir (200 mg) tablet is Rs 600 in Russia, Rs 378 in Japan, Rs 350 in Bangladesh and Rs 215 in China. (*Currency rates in respective countries equivalent to Indian rupee). Recently, Glenmark lowered the price of FabiFlu to Rs 75 from Rs 103 per tablet.


Stay updated with the latest news on Times of India. Don't miss daily games like Crossword, Sudoku, and Mini Crossword.
Continue Reading
Follow Us On Social Media
end of article
More Trending Stories
Visual Stories
More Visual Stories
UP NEXT
Do Not Sell Or Share My Personal Information